MedTrace Logo

The Role of Hypertonic Dextrose Spray as Endoscopic Topical Hemostatic Agent for Acute Non-Variceal Upper GI Bleeding

NCT04979273 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2021-07-28

No results posted yet for this study

Summary

This study is conducted to evaluate the effectivity of hypertonic dextrose spray as an endoscopic topical hemostatic agent, compared to conventional agent (adrenaline injection, followed by hemoclip or thermocoagulation), in patients with acute non-variceal upper GI bleeding.

Conditions

  • Gastro Intestinal Bleeding

Interventions

DRUG

Dextrose 40 % in Water

injection of adrenaline 1:20.000, followed by dextrose 40% spray

DRUG

Adrenaline 1 Mg/mL Solution for Injection

injection of adrenaline 1:20.000, followed by thermocoagulation or hemoclip

PROCEDURE

argon plasma coagulation

Thermocoagulation

PROCEDURE

Hemoclip

Hemoclip

Sponsors & Collaborators

  • Dr Cipto Mangunkusumo General Hospital

    lead OTHER

Principal Investigators

  • Hasan Maulahela, MD · Dr Cipto Mangunkusumo General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04979273 on ClinicalTrials.gov